Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines

Ann N Y Acad Sci. 1995 May 31:754:68-82. doi: 10.1111/j.1749-6632.1995.tb44439.x.

Authors

J B Robbins¹, R Schneerson, W F Vann, D A Bryla, A Fattom

Affiliation

¹ National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

PMID: 7625682
DOI: 10.1111/j.1749-6632.1995.tb44439.x

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial
Review

MeSH terms

Bacterial Capsules / immunology*
Carbohydrate Sequence
Female
Humans
Molecular Sequence Data
Polysaccharides, Bacterial / immunology*
Pregnancy
Pregnancy Complications, Infectious / prevention & control
Rubella / prevention & control
Staphylococcal Infections / prevention & control*
Staphylococcus aureus / immunology
Streptococcal Infections / prevention & control*
Streptococcus agalactiae / immunology
Vaccines, Conjugate / therapeutic use*

Substances

Polysaccharides, Bacterial
Vaccines, Conjugate